Cyberknife

Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024

Retrieved on: 
torsdag, april 25, 2024
Cancer, Congress, IMRT, Physics, Cyberknife, Health, Tomotherapy, Software, Patient, University, Royal Marsden Hospital, Radiation therapy, Malignancy, MBA, Neuro, Medical imaging

MADISON, Wis., April 25, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company is showcasing advances in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024. The latest generation CyberKnife® and Radixact® platforms provide medical care teams with the technology necessary for expanding the curative power of radiation therapy and delivering on the focus of this year's congress, bridging the care gap. The European Society for Radiotherapy and Oncology's (ESTRO) annual meeting will take place May 3 to May 7, 2024, in Glasgow, Scotland.

Key Points: 
  • MADISON, Wis., April 25, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company is showcasing advances in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024.
  • The European Society for Radiotherapy and Oncology's (ESTRO) annual meeting will take place May 3 to May 7, 2024, in Glasgow, Scotland.
  • Accuray is a wellness focused organization, taking into account the patient's health and well-being throughout their treatment when prioritizing product enhancements.
  • Uniformity in image quality and consistency in Hounsfield units validate their use in this important step in the radiation therapy treatment workflow.

Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland

Retrieved on: 
torsdag, april 18, 2024
Cancer, Radiation treatment planning, Risk, Cyberknife, Radiation, Partnership, Radiosurgery, Neurosurgery, DSM-IV codes, Patient, Faculty, Health, Quality of life, Knowledge, Nursing

The Genolier based center is the most recent addition to the Accuray network of advanced training facilities with sites located strategically around the world to make it easier for medical care teams to obtain state-of-the-art clinical education.

Key Points: 
  • The Genolier based center is the most recent addition to the Accuray network of advanced training facilities with sites located strategically around the world to make it easier for medical care teams to obtain state-of-the-art clinical education.
  • The Genolier training facility includes hands-on simulation facilities for the CyberKnife and Radixact Systems to be used for training and demonstrations, and meeting rooms equipped with the most advanced technologies to host seminars, workshops and educational events.
  • The center sits within the Genolier Innovation Hub, a fully-owned subsidiary of AEVIS VICTORIA SA, whose grand opening will occur later this year.
  • "People diagnosed with cancer rely on their medical team to recommend and deliver a personalized, precise and safe treatment for their specific condition.

New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System

Retrieved on: 
tisdag, mars 26, 2024
Radiation, Prostate cancer, Disease, Incidence, Patient, Rectum, RSS, Prostate, Motion, SBRT, Quality of life, Cyberknife, MBA, Neoplasm, Accuray, Movement, Health, Medical imaging

MADISON, Wis., March 26, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the 2024 Radiosurgery Society Meeting in Chicago, Illinois support the use of the CyberKnife® System in the treatment of high-risk and recurrent prostate cancer. The studies expand on years of published clinical follow-up with a large number of prostate cancer patients with various stages of disease, as well as with those who were previously treated with radiotherapy – supporting the system's versatility and value to medical care teams.

Key Points: 
  • "An extensive number of peer-reviewed scientific manuscripts have been published reporting on CyberKnife prostate SBRT efficacy and tolerability.
  • The system's precision enables clinicians to confidently treat the prostate gland, which is situated near the sensitive bladder and rectum, with SBRT.
  • Provide a viable option with "a low incidence of short-term genitourinary (GU) and gastrointestinal (GI) toxicities" for reirradiation of locally recurrent prostate cancer2.
  • For example, if the prostate moves during treatment the CyberKnife® System detects this movement and synchronizes the treatment delivery beam to the tumor's new position in real-time.

In the War on Cancer, Tampa General Hospital Cancer Institute Employs AI in its Newly Established Center for Precision Radiosurgery

Retrieved on: 
torsdag, januari 25, 2024
Proton, Kidney, Neck, Cancer, Prostate, Brachytherapy, Neoplasm, Sarcoma, Health, Georgetown University, HDR, Movement, Brain, Liver, Bone marrow, Cancer Institute, Lung, DSM-IV codes, Tampa General Hospital, Proton therapy, Cyberknife, Radiopharmaceutical, Radiation therapy, Radiation, Stereotactic surgery, AI, Spine, TGH, Elective surgery, SRS, Patient, Federal Medical Centres, Breast cancer, Head, SBRT, Pancreas, Medical imaging

TAMPA, Fla., Jan. 25, 2024 /PRNewswire/ -- Going under the knife is taking on a new and more promising meaning at Tampa General Hospital (TGH) Cancer Institute, where doctors are using a sophisticated AI-driven tool to treat cancer.

Key Points: 
  • TAMPA, Fla., Jan. 25, 2024 /PRNewswire/ -- Going under the knife is taking on a new and more promising meaning at Tampa General Hospital (TGH) Cancer Institute , where doctors are using a sophisticated AI-driven tool to treat cancer.
  • It is capable of treating cancerous and benign tumors throughout the body, as well as neurologic disorders, in as little as 15 minutes.
  • The tool, through its speed and advanced precision, is expected to expand the capabilities of Tampa General Cancer Institute's newly established Center for Precision Radiosurgery, said Dr. Richard Tuli, professor and chair of the Department of Radiation Oncology at USF Health Morsani College of Medicine, deputy director of the TGH Cancer Institute, and director of Radiation Oncology at Tampa General.
  • Tuli joined TGH from Memorial Sloan Kettering Cancer Center in New York, N.Y.
    "It's another example of providing our patients with the best possible care across the Tampa Bay region and the state,'' he said.

Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions

Retrieved on: 
torsdag, januari 25, 2024
Cyberknife, Artificial intelligence, Neoplasm, Patient, Research, Prostate cancer, Health, Partnership, Radiosurgery, Cancer, Quality of life, Gold, Movement, SBRT, DSM-IV codes, SRS, Brain, Estate (law), Medical imaging

MADISON, Wis., Jan. 25, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Providence Swedish Radiosurgery Center in Seattle, Washington is enhancing its cancer treatment capabilities with the purchase of the latest generation CyberKnife® S7™ System, the hospital's second CyberKnife radiation delivery device purchase. The precision and accuracy enabled by the system's robotic design will also make it an ideal choice for the treatment of neurologic disorders. The new system will enable the medical team to deliver gold standard stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments faster than with previous models, expanding access to an effective and convenient option to more patients.

Key Points: 
  • The precision and accuracy enabled by the system's robotic design will also make it an ideal choice for the treatment of neurologic disorders.
  • "The Providence Swedish Radiosurgery Center began using their first CyberKnife System more than 10 years ago.
  • "I couldn't be prouder that the Providence Swedish Radiosurgery team is continuing to invest in Accuray technologies.
  • "At Providence Swedish Radiosurgery Center, we recognize that treatment decisions significantly impact patients' immediate health and long term quality of life.

RaySearch Laboratories: Interim report January 1 - September 30, 2023

Retrieved on: 
fredag, november 17, 2023
Paul Scherrer Institute, CFO, Mass, Cyberknife, CET, University Medical Center Groningen, RaySearch Laboratories, Lausanne University Hospital, University, Partnership, CHUV, Pharmaceutical industry, Nursing, Flour

RaySearch and MedAustron expand their partnership through a new strategic research agreement.

Key Points: 
  • RaySearch and MedAustron expand their partnership through a new strategic research agreement.
  • RaySearch's business partner IBA has placed an order for RayStation and RayCare for installation at CRO National Cancer Institute (C.R.O.)
  • RaySearch has received an order from Israel-based P-Cure and is deepening its collaboration focusing on advanced proton therapy solutions.
  • CEO Johan Löf and interim CFO Annika Blondeau Henriksson will present RaySearch's interim report for January - September 2023 at a webcast to be held in English on Friday, November 17, 2023 at 10:00-10:30 a.m. CET.

Baptist Health Lexington selects RayStation

Retrieved on: 
torsdag, oktober 26, 2023
Cyberknife, Tomotherapy, RaySearch Laboratories, Patient, Workflow, Pharmaceutical industry, Accuray, Elekta, Varian

STOCKHOLM, Oct. 26, 2023 /PRNewswire/ -- RayStation will be used to treat patients at Baptist Health Lexington as well as Baptist Health Hamburg. It will be used to plan for a wide range of delivery systems, including linear accelerators from Elekta and Varian as well as CyberKnife and Tomotherapy from Accuray. RayStation will also be used for high dose rate brachytherapy planning. The configuration includes advanced features such as fallback planning, multi-criteria optimization, dose tracking and adaptive radiation therapy.

Key Points: 
  • RaySearch Laboratories AB (publ) announces that Baptist Health Lexington, Kentucky, USA, has begun implementation of the treatment planning system RayStation®*.
  • STOCKHOLM, Oct. 26, 2023 /PRNewswire/ -- RayStation will be used to treat patients at Baptist Health Lexington as well as Baptist Health Hamburg.
  • Chris Roty, President, Baptist Health Lexington, says: "We are pleased to be able to implement RayStation in our Baptist System.
  • Right now, RayStation is the only treatment planning system available that can facilitate a unified workflow for such large and diversified centers as Baptist Health Lexington and Baptist Health Hamburg and we are looking forward to a successful collaboration."

Accuray and Limbus AI Unveil Online Adaptive Therapy Solution for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting

Retrieved on: 
måndag, oktober 2, 2023
SBRT, Cyberknife, SRS, CE, Radiation, Partnership, DIBH, Workflow, Alliance University (New York City), Neoplasm, ASTRO, Cancer, Radiation therapy, Sale, Limbus, Patient, Risk, Annual general meeting, Physics, Society, American Society for Radiation Oncology, Software, Medical device, Medical imaging, EU, Accuray, Ceno

The solution was unveiled, in partnership with Limbus AI, at the 2023 ASTRO (American Society for Radiation Oncology) Annual Meeting in San Diego, California, October 1-4, 2023.

Key Points: 
  • The solution was unveiled, in partnership with Limbus AI, at the 2023 ASTRO (American Society for Radiation Oncology) Annual Meeting in San Diego, California, October 1-4, 2023.
  • Accuray customers are currently able to leverage real-time adaptive therapy through the company's proprietary Synchrony® technology and offline adaptive with PreciseART® radiotherapy to account for some of the anatomical changes that occur during radiation delivery.
  • "We're very happy to be partnering with Accuray," said Dr Karl Otto, CEO of Limbus AI.
  • Embedding it into the Cenos online adaptive solution will help provide for accurate and fast contouring essential to real-world clinical implementation of adaptive treatment."

Accuray Opens New Global Training Center at Madison, WI Headquarters to Advance Radiotherapy Treatment Techniques Amid Growing Demand for Precision Cancer Care

Retrieved on: 
måndag, september 18, 2023
Cyberknife, CE, Cancer, Patient, Tomotherapy, Knowledge, Health, Education, Nursing, Accuray

Different education modalities - from in-person at the Accuray facility to on-site and self-paced, remote – enable medical teams to choose when and how they learn.

Key Points: 
  • Different education modalities - from in-person at the Accuray facility to on-site and self-paced, remote – enable medical teams to choose when and how they learn.
  • "Our customers are passionate about improving the lives of people diagnosed with cancer and certain neurologic conditions.
  • Short, convenient education modules developed in response to customer feedback and led by Accuray clinical specialists.
  • A platform for CyberKnife, TomoTherapy and Radixact System users to gain knowledge and build partnerships focused on improving the treatment of cancer and neurologic conditions.

RaySearch Laboratories : Interim report January 1 - June 30, 2023

Retrieved on: 
fredag, augusti 25, 2023
Proton, Cyberknife, Partnership, EU, RaySearch Laboratories, Medical examiner, CEST, Proton therapy, CFO, Research, University Medical Center Groningen, Lausanne University Hospital, Pharmaceutical industry, Flour

New York University Langone Hospital, USA, placed an order for RayStation, which will replace its current treatment planning system.

Key Points: 
  • New York University Langone Hospital, USA, placed an order for RayStation, which will replace its current treatment planning system.
  • Shinva, a Chinese radiation therapy machine manufacturer, placed an order for 15 RayPlan systems for onwards sales to customers in China.
  • The total number of registered shares in RaySearch amounts to 34,282,773 of which 7,654,975 are Class A shares and 26,627,798 are Class B shares.
  • CEO Johan Löf and interim CFO Annika Blondeau Henriksson will present RaySearch's interim report for January -June 2023 at a webcast to be held in English on Friday, August 25, 2023 at 10:00-10:30 a.m. CEST.